News & Events

Philogen publishes a new study in Pharmaceutics

Feb 2, 2023

Philogen announces the publication of a study in the peer-reviewed journal “Pharmaceutics” describing the development and the in vitro/vivo characterization of a novel interferon-gamma (IFNg) based antibody fusion protein.

The paper can be accessed from the Pharmaceutics website under the following link.

For more details